Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. J Thorac Oncol 2009 May;4(5):661-2

Date

04/28/2009

Pubmed ID

19395911

DOI

10.1097/JTO.0b013e31819c9a73

Scopus ID

2-s2.0-67651159238 (requires institutional sign-in at Scopus site)   35 Citations

Abstract

Ocular metastasis from lung cancer is uncommon. We report a patient with metastatic non-small cell lung cancer who was found to have a metastatic lesion in the choroid at the time of presentation. The patient was treated with carboplatin, gemcitabine, and bevacizumab. After three cycles of chemotherapy, radiologic imaging and ophthalmologic examination demonstrated complete resolution of the choroid lesion. This case report demonstrates the durable response of choroidal metastasis from non-small cell lung cancer to systemic bevacizumab and chemotherapy.

Author List

George B, Wirostko WJ, Connor TB, Choong NW

Authors

Thomas B. Connor MD Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin
Ben George MD Professor in the Medicine department at Medical College of Wisconsin
William Wirostko MD Professor in the Ophthalmology and Visual Sciences department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Carboplatin
Carcinoma, Non-Small-Cell Lung
Choroid Neoplasms
Deoxycytidine
Female
Humans
Lung Neoplasms
Prognosis
Treatment Outcome